1. Home
  2. ORIC vs AROW Comparison

ORIC vs AROW Comparison

Compare ORIC & AROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • AROW
  • Stock Information
  • Founded
  • ORIC 2014
  • AROW 1851
  • Country
  • ORIC United States
  • AROW United States
  • Employees
  • ORIC N/A
  • AROW N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • AROW Major Banks
  • Sector
  • ORIC Health Care
  • AROW Finance
  • Exchange
  • ORIC Nasdaq
  • AROW Nasdaq
  • Market Cap
  • ORIC 362.9M
  • AROW 418.8M
  • IPO Year
  • ORIC 2020
  • AROW N/A
  • Fundamental
  • Price
  • ORIC $8.17
  • AROW $25.75
  • Analyst Decision
  • ORIC Strong Buy
  • AROW Hold
  • Analyst Count
  • ORIC 8
  • AROW 1
  • Target Price
  • ORIC $18.83
  • AROW $28.00
  • AVG Volume (30 Days)
  • ORIC 1.6M
  • AROW 43.6K
  • Earning Date
  • ORIC 05-05-2025
  • AROW 07-24-2025
  • Dividend Yield
  • ORIC N/A
  • AROW 4.35%
  • EPS Growth
  • ORIC N/A
  • AROW N/A
  • EPS
  • ORIC N/A
  • AROW 1.70
  • Revenue
  • ORIC N/A
  • AROW $135,107,000.00
  • Revenue This Year
  • ORIC N/A
  • AROW $23.54
  • Revenue Next Year
  • ORIC N/A
  • AROW $7.07
  • P/E Ratio
  • ORIC N/A
  • AROW $15.15
  • Revenue Growth
  • ORIC N/A
  • AROW 3.10
  • 52 Week Low
  • ORIC $3.90
  • AROW $22.72
  • 52 Week High
  • ORIC $14.67
  • AROW $34.63
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 72.38
  • AROW 49.04
  • Support Level
  • ORIC $5.52
  • AROW $25.44
  • Resistance Level
  • ORIC $8.44
  • AROW $26.54
  • Average True Range (ATR)
  • ORIC 0.63
  • AROW 0.51
  • MACD
  • ORIC 0.32
  • AROW -0.08
  • Stochastic Oscillator
  • ORIC 93.11
  • AROW 15.66

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.

Share on Social Networks: